Decrease in diluted earnings per share due to the write-off of deferred tax assets associated with retiree prescription drug expenses. Previously, a portion of such expenses were tax deductible. However, in March 2010, the President signed into law the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010, which eliminated the tax deduction available to the extent that those expenses are reimbursed under Medicare Part D beginning January 1, 2013.

Income Tax Expense Decrease Resulting From Resolution Of Previous Tax Matters

Income tax expense per share decreases resulting from resolution of previous tax matters.

Increase in income tax expense due to the write-off of deferred tax assets associated with retiree prescription drug expenses. Previously, a portion of such expenses were tax deductible. However, in March 2010, the President signed into law the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010, which eliminated the tax deduction available to the extent that those expenses are reimbursed under Medicare Part D beginning January 1, 2013.

Percentage of total lump-sum special payments made in the period

Number Of Days From Separation For Effecting Cash Special Payment

Reduction in net earnings due to severance charges.

Reduction in net earnings per share due to severance charges.

The charge against earnings in the period for known and estimated costs of termination benefits provided to current employees that are voluntarily and involuntarily terminated under a benefit arrangement associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, excluding costs or losses pertaining to an entity newly acquired in a business combination or a discontinued operation as defined by generally accepted accounting principles and costs associated with one-time termination benefits.

Charge related to a Voluntary Executive Separation Program